Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
bacterial species. Our vision is to develop customized chemical tools for precise interventions in the human microbiome and thus create the basis for chemical microbiome engineering for the future. Our
-
the Research Group Workflow Systems and Technology (WST) at the Faculty of Computer Science and will work towards obtaining a doctorate degree (PhD) under the supervision of Prof. Han van der Aa. The position is
-
supports a safe, equitable, and sustainable approach to tackling AMR. Anchored in Science and Technology Studies (STS) research perspectives, ALTERBIOTIC analyses the entanglements and the tensions between
-
sustainable approach to tackling AMR. Anchored in Science and Technology Studies (STS) research perspectives, ALTERBIOTIC analyses the entanglements and the tensions between scientific, political and economic
-
well as innovation and technology for collective spatial action. You will take on administrative tasks in research and teaching. This is part of your personal orientation: Completed master's or diploma degree in one
-
of probability distributions in systems driven by stochastic processes with Brownian motion. It plays a crucial role across a wide range of fields, from physics and biology to finance and engineering. But there's
-
: Completed secondary education, e.g. HTL Mechanical Engineering. Very good German language skills (fluent in writing and speaking) and sufficient skills in English (B2 level or higher; no certificate required
-
personality: For this position, it is mandatory that you have a relevant university education in computer science or electrical engineering or a related field. Likewise, your research subject must be in
-
Quantum Information group of the Faculty of Physics. We are a member of the Vienna Center for Quantum Science and Technology (VCQ), one of the largest quantum hubs in Europe, and of the Austrian Cluster
-
- Pharmaceutical Division. Technology & Supplement and complete biopharmaceuticals. The focus of our research is on RNA and CRISPR/Cas9 technologies and these will revolutionize future treatment of patients